Indications and uses
First aid to help prevent bacterial infection associated with contamination or skin infection, and for the temporary relief of pain and itching associated with minor: : Burns Cuts Sunburn Scrapes Minor Skin Irritations
First aid to help prevent bacterial infection associated with contamination or skin infection, and for the temporary relief of pain and itching associated with minor: : Burns Cuts Sunburn Scrapes Minor Skin Irritations
Adults and children 2 years of age and older: Clean the affected area. Apply a small amount of gel on the affected area not more than 3 to 4 times daily. May be covered with a sterile bandgae (let dry first). Children under 2 years of age: ask a doctor.
Benzalkonium Chloride 0.13%
Lidocaine HCl 4.0%
First Aid Antiseptic
External Analgesic
First aid to help prevent bacterial infection associated with contamination or skin infection, and for the temporary relief of pain and itching associated with minor: :
For external use only.
Ask a doctor before use if you have:
Do not use:
Stop use and ask doctor: If condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days.
If pregnant or breast-feeding, ask a health care professional before use.
Keep out of reach of children. If swallowed, get medical help or call a Poison Control Center right away.
Adults and children 2 years of age and older: Clean the affected area. Apply a small amount of gel on the affected area not more than 3 to 4 times daily. May be covered with a sterile bandgae (let dry first).
Children under 2 years of age: ask a doctor.
Store at room temperature 15°-30°C (59°-86°F)
Aloe Barbadensis (Aloe) Leaf Juice, Dimethyl Isosorbide, Disodium EDTA, Ethylhexyglycerin, Hydroxyethyl Cellulose, Phenoxyethanol, Propanediol, Sodium Hydroxide, Tocopheryl Acetate (Vitamin E), Water.
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 2587646 | ALOCANE plus 4 % / 0.13 % Topical Gel | PSN | 7 |
| 2375042 | benzalkonium chloride 0.13 % / lidocaine hydrochloride 4 % Topical Gel | PSN | 7 |
| 2587646 | benzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.04 MG/MG Topical Gel [Alocane Plus] | SBD | 7 |
| 2375042 | benzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.04 MG/MG Topical Gel | SCD | 7 |
| 2587646 | Alocane Plus (benzalkonium chloride 0.13 % / lidocaine hydrochloride 4 % ) Topical Gel | SY | 7 |
| 2375042 | benzalkonium chloride 0.13 % / lidocaine hydrochloride 4 % Topical Gel | SY | 7 |
| Class | Version | Type | Effective |
|---|---|---|---|
| LIDOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 070fbed5-7088-434a-a7ce-f2a64d8d40ac | Product name | 2 | 20260107 |
| bee66ce1-adb7-9d3b-67d9-582e4c54e80f | Product name | 5 | 20250819 |
| 860a93dc-4863-49cc-b284-6bbe8191bc48 | Product name | 4 | 20250214 |
| eaba870a-6a9d-442e-8643-87b3f558a451 | Product name | 1 | 20250117 |
| 9b4cf230-fd05-41d5-98c6-5db9ecb27b86 | Product name | 1 | 20230117 |
| 7d755fa1-1087-4dcd-98f0-6d4bba479a57 | Product name | 3 | 20210602 |
| aed701d5-9c75-dfaf-7154-cde46179faea | Product name | 9 | 20200313 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| 332d03e4-aa24-4b11-841a-02bf41081920 | Product name | 1 | 20171221 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 68ed98f8-24c2-44a0-944a-6d36e82ce25a | Product name | 1 | 20141222 |
| 1cd42bc2-a430-c72b-636d-991b235fbf80 | Product name | 1 | 20140508 |
| 49fa150c-f0de-cce7-3d9c-993ed81c5698 | Product name | 1 | 20140508 |
| 4d7ae718-ed00-bae8-2abe-9eaec1eef7ff | Product name | 1 | 20140508 |
| 9137811f-f279-8640-5aeb-99fa2145d64d | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68229-406-01 | Alocane Max | 75 mL in 1 TUBE | GEL | 75 | 7 | |
| 68229-406-02 | Alocane Max | 1 in 1 CARTON | GEL | 1 | 7 | |
| 68229-406-03 | Alocane Max | 118 mL in 1 TUBE | GEL | 118 | 7 | |
| 68229-406-05 | Alocane Max | 1 in 1 CARTON | GEL | 1 | 7 | |
| 68229-406-06 | Alocane Max | 3.4 mL in 1 PACKET | GEL | 3.4 | 7 | |
| 68229-406-07 | Alocane Max | 24 in 1 CARTON | GEL | 24 | 7 | |
| 68229-406-08 | Alocane Max | 110 mL in 1 TUBE | GEL | 110 | 7 | |
| 68229-406-09 | Alocane Max | 1 in 1 CARTON | GEL | 1 | 7 | |
| 68229-406-10 | Alocane Max | 59 mL in 1 TUBE | GEL | 59 | 7 | |
| 68229-406-11 | Alocane Max | 1 in 1 CARTON | GEL | 1 | 7 | |
| 68229-406-85 | Alocane Max | 251.4 mL in 1 TUBE | GEL | 251.4 | 7 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68229-406-02 | ML - Milliliter | 68229-406 | 1d96aaae-85fa-4d02-af55-4e0e1508ec58 | 1 | 2023-12-05 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68229-406 | 68229-406-01, 68229-406-02, 68229-406-03, 68229-406-05, 68229-406-06, 68229-406-07, 68229-406-08, 68229-406-09, 68229-406-10, 68229-406-11, 68229-406-85 |
Every source-derived ingredient row is available through these pages.
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 6 | 2025-12-04 | monthly-update | 2026-06-03 17:45:24 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Alocane Max | LIDOCAINE HYDROCHLORIDE AND BENZALKONIUM CHLORIDE | Quest Products LLC | 0a33f9a9-1fdc-7cdf-e063-6294a90adca1 | 2026-03-25 | Warnings | 68229-406-01 68229-406-02 68229-406-08 68229-406-09 68229-406-11 68229-406-85 68229-406-03 68229-406-07 68229-406-06 68229-406-10 68229-406-05 68229-406 68229040608 68229040602 68229040685 68229040601 68229040605 68229040606 68229040603 68229040609 68229040611 68229040610 68229040607 4de08098-5946-ba6e-e063-6294a90a8dbe 0a33f9a9-1fdc-7cdf-e063-6294a90adca1 |
Adverse event summaries are temporarily unavailable. Other product information remains available.